A detailed history of Kelly Financial Services LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Kelly Financial Services LLC holds 414 shares of LLY stock, worth $336,089. This represents 0.14% of its overall portfolio holdings.

Number of Shares
414
Previous 414 -0.0%
Holding current value
$336,089
Previous $374,000 2.14%
% of portfolio
0.14%
Previous 0.14%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jul 17, 2024

SELL
$592.2 - $792.28 $10,659 - $14,261
-18 Reduced 4.17%
414 $322,000
Q4 2023

Jul 17, 2024

SELL
$525.19 - $619.13 $36,763 - $43,339
-70 Reduced 13.94%
432 $252 Million
Q2 2023

Jul 17, 2024

SELL
$350.74 - $468.98 $29,462 - $39,394
-84 Reduced 14.33%
502 $235 Million
Q1 2023

Jul 17, 2024

SELL
$310.63 - $364.82 $1,553 - $1,824
-5 Reduced 0.85%
586 $201 Million
Q4 2022

Jul 17, 2024

SELL
$321.55 - $374.67 $15,755 - $18,358
-49 Reduced 7.66%
591 $216 Million
Q3 2022

Jul 17, 2024

SELL
$296.48 - $337.87 $2,668 - $3,040
-9 Reduced 1.39%
640 $207 Million
Q2 2022

Jul 17, 2024

SELL
$278.73 - $327.27 $1,393 - $1,636
-5 Reduced 0.76%
649 $211 Million
Q4 2021

Jul 17, 2024

SELL
$224.85 - $279.04 $1,349 - $1,674
-6 Reduced 0.91%
654 $181 Million
Q3 2021

Jul 17, 2024

SELL
$221.6 - $272.71 $33.4 Million - $41.1 Million
-150,828 Reduced 99.56%
660 $153 Million
Q2 2021

Jul 17, 2024

BUY
$180.55 - $233.54 $27.2 Million - $35.2 Million
150,828 Added 22852.73%
151,488 $660,000
Q4 2020

Jul 17, 2024

SELL
$130.46 - $172.63 $2,087 - $2,762
-16 Reduced 2.37%
660 $111 Million
Q2 2020

Jul 17, 2024

SELL
$136.42 - $164.18 $13,641 - $16,418
-100 Reduced 12.89%
676 $111 Million
Q3 2019

Jul 17, 2024

BUY
$106.79 - $116.16 $5,019 - $5,459
47 Added 6.45%
776 $86.8 Million
Q1 2019

Jul 17, 2024

BUY
$111.31 - $131.02 $81,144 - $95,513
729 New
729 $94.6 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $771B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.